Join us in exploring a potential new option for carotid artery disease

ACT I is a new clinical study in carotid artery disease. The ACT I study will compare carotid artery stenting (CAS) to carotid endarterectomy (CEA) surgery for the treatment of patients who are symptom-free and at standard risk for surgery.

Enrollment for the ACT I study is now underway. Up to 1,858 patients will be enrolled in at least 50 sites throughout North America. More information about ACT I can be found on this Web site.

Click the buttons below to find more information about the ACT I study.

Patients and Public

Patients and Public
Learn more about ACT I
  and carotid artery disease
Healthcare Professionals

Healthcare Professionals
ACT I background, rationale,
  trial sites, and resources
Investigators

Investigators
ACT I trial updates, news,
  information, and enrollment
  materials
Password-protected resources


Carotid stenting is not currently approved by the FDA for asymptomatic patients who are at standard risk for surgery.
CAUTION: Investigational device. Limited by Federal (or United States) law to investigational use.